Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Sep-Oct;7(5):780–788. doi: 10.3201/eid0705.010503

Potential infectious etiologies of atherosclerosis: a multifactorial perspective.

S O'Connor 1, C Taylor 1, L A Campbell 1, S Epstein 1, P Libby 1
PMCID: PMC2631877  PMID: 11747688

Abstract

Coronary heart disease (CHD) contributes substantially to illness and death worldwide. Experimental studies demonstrate that infection can stimulate atherogenic processes. This review presents a spectrum of data regarding the link between CHD and infection. In addition, the need for improved diagnostic tools, the significance of multiple pathogens, and potential intervention strategies are discussed.

Full Text

The Full Text of this article is available as a PDF (94.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. P., Hur J. K., Wang J. B., Vetrovec G. W. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis. 1998 Jan;177(1):209–212. doi: 10.1086/517355. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. L., Muhlestein J. B., Carlquist J., Allen A., Trehan S., Nielson C., Hall S., Brady J., Egger M., Horne B. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation. 1999 Mar 30;99(12):1540–1547. doi: 10.1161/01.cir.99.12.1540. [DOI] [PubMed] [Google Scholar]
  3. Arason V. A., Kristinsson K. G., Sigurdsson J. A., Stefánsdóttir G., Mölstad S., Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ. 1996 Aug 17;313(7054):387–391. doi: 10.1136/bmj.313.7054.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bachmaier K., Neu N., de la Maza L. M., Pal S., Hessel A., Penninger J. M. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999 Feb 26;283(5406):1335–1339. doi: 10.1126/science.283.5406.1335. [DOI] [PubMed] [Google Scholar]
  5. Barber D. A., Burnett J. C., Jr, Fitzpatrick L. A., Sieck G. C., Miller V. M. Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries. J Cardiovasc Pharmacol. 1998 Jul;32(1):5–11. doi: 10.1097/00005344-199807000-00002. [DOI] [PubMed] [Google Scholar]
  6. Bartels C., Maass M., Bein G., Brill N., Bechtel J. F., Leyh R., Sievers H. H. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation. 2000 Jan 18;101(2):137–141. doi: 10.1161/01.cir.101.2.137. [DOI] [PubMed] [Google Scholar]
  7. Blasi F., Boman J., Esposito G., Melissano G., Chiesa R., Cosentini R., Tarsia P., Tshomba Y., Betti M., Alessi M. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis. 1999 Dec;180(6):2074–2076. doi: 10.1086/315126. [DOI] [PubMed] [Google Scholar]
  8. Blessing E., Lin T. M., Campbell L. A., Rosenfeld M. E., Lloyd D., Kuo C. Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect Immun. 2000 Aug;68(8):4765–4768. doi: 10.1128/iai.68.8.4765-4768.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Boman J., Söderberg S., Forsberg J., Birgander L. S., Allard A., Persson K., Jidell E., Kumlin U., Juto P., Waldenström A. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis. 1998 Jul;178(1):274–277. doi: 10.1086/517452. [DOI] [PubMed] [Google Scholar]
  10. Campbell L. A., Kuo C. C., Grayston J. T. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998 Oct-Dec;4(4):571–579. doi: 10.3201/eid0404.980407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Centers for Disease Control and Prevention (CDC) Decline in deaths from heart disease and stroke--United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999 Aug 6;48(30):649–656. [PubMed] [Google Scholar]
  12. Clinton S. K., Fleet J. C., Loppnow H., Salomon R. N., Clark B. D., Cannon J. G., Shaw A. R., Dinarello C. A., Libby P. Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am J Pathol. 1991 Apr;138(4):1005–1014. [PMC free article] [PubMed] [Google Scholar]
  13. Craighead J. E. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines. J Infect Dis. 1975 Jun;131(6):749–754. doi: 10.1093/infdis/131.6.749. [DOI] [PubMed] [Google Scholar]
  14. Dagan R., Leibovitz E., Greenberg D., Yagupsky P., Fliss D. M., Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J. 1998 Oct;17(10):880–885. doi: 10.1097/00006454-199810000-00006. [DOI] [PubMed] [Google Scholar]
  15. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997 Aug 9;350(9075):430–436. doi: 10.1016/S0140-6736(97)03079-1. [DOI] [PubMed] [Google Scholar]
  16. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Wong Y., Bernardes-Silva M., Ward M. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ. 2000 Jul 22;321(7255):208–213. doi: 10.1136/bmj.321.7255.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Davidson M., Kuo C. C., Middaugh J. P., Campbell L. A., Wang S. P., Newman W. P., 3rd, Finley J. C., Grayston J. T. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998 Aug 18;98(7):628–633. doi: 10.1161/01.cir.98.7.628. [DOI] [PubMed] [Google Scholar]
  18. Ericson K., Saldeen T. G., Lindquist O., Pâhlson C., Mehta J. L. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation. 2000 Jun 6;101(22):2568–2571. doi: 10.1161/01.cir.101.22.2568. [DOI] [PubMed] [Google Scholar]
  19. Gaydos C. A., Quinn T. C. The role of Chlamydia pneumoniae in cardiovascular disease. Adv Intern Med. 2000;45:139–173. [PubMed] [Google Scholar]
  20. Gaydos C. A., Summersgill J. T., Sahney N. N., Ramirez J. A., Quinn T. C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996 May;64(5):1614–1620. doi: 10.1128/iai.64.5.1614-1620.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gilbert DN. Preface. J Infect Dis. 2000 Jun;181(Suppl 3):S393–S393. doi: 10.1086/315638. [DOI] [PubMed] [Google Scholar]
  22. Gulizia J. M., Kandolf R., Kendall T. J., Thieszen S. L., Wilson J. E., Radio S. J., Costanzo M. R., Winters G. L., Miller L. L., McManus B. M. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol. 1995 Aug;147(2):461–475. [PMC free article] [PubMed] [Google Scholar]
  23. Gupta S., Leatham E. W., Carrington D., Mendall M. A., Kaski J. C., Camm A. J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997 Jul 15;96(2):404–407. doi: 10.1161/01.cir.96.2.404. [DOI] [PubMed] [Google Scholar]
  24. Gurfinkel E., Bozovich G., Beck E., Testa E., Livellara B., Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J. 1999 Jan;20(2):121–127. doi: 10.1053/euhj.1998.1283. [DOI] [PubMed] [Google Scholar]
  25. Haraszthy V. I., Zambon J. J., Trevisan M., Zeid M., Genco R. J. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000 Oct;71(10):1554–1560. doi: 10.1902/jop.2000.71.10.1554. [DOI] [PubMed] [Google Scholar]
  26. Hoogwerf B. J., Young J. B. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med. 2000 Apr;67(4):287–293. doi: 10.3949/ccjm.67.4.287. [DOI] [PubMed] [Google Scholar]
  27. Hosenpud J. D. Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J. 1999 Nov;138(5 Pt 2):S469–S472. doi: 10.1016/s0002-8703(99)70277-2. [DOI] [PubMed] [Google Scholar]
  28. Hu H., Pierce G. N., Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest. 1999 Mar;103(5):747–753. doi: 10.1172/JCI4582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Joshipura K. J., Douglass C. W., Willett W. C. Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol. 1998 Jul;3(1):175–183. doi: 10.1902/annals.1998.3.1.175. [DOI] [PubMed] [Google Scholar]
  30. Kalayoglu M. V., Hoerneman B., LaVerda D., Morrison S. G., Morrison R. P., Byrne G. I. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis. 1999 Sep;180(3):780–790. doi: 10.1086/314931. [DOI] [PubMed] [Google Scholar]
  31. Karvonen M., Tuomilehto J., Pitkäniemi J., Naukkarinen A., Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol. 1994 Dec;23(6):1315–1321. doi: 10.1093/ije/23.6.1315. [DOI] [PubMed] [Google Scholar]
  32. Kol A., Bourcier T., Lichtman A. H., Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest. 1999 Feb;103(4):571–577. doi: 10.1172/JCI5310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Koskinen P., Lemstrøm K., Mattila S., Häyry P., Nieminen M. S. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft. Clin Transplant. 1996 Dec;10(6 Pt 1):487–493. [PubMed] [Google Scholar]
  34. Laitinen K., Laurila A., Pyhälä L., Leinonen M., Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997 Nov;65(11):4832–4835. doi: 10.1128/iai.65.11.4832-4835.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Leach A. J., Shelby-James T. M., Mayo M., Gratten M., Laming A. C., Currie B. J., Mathews J. D. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis. 1997 Mar;24(3):356–362. doi: 10.1093/clinids/24.3.356. [DOI] [PubMed] [Google Scholar]
  36. Lemström K., Sihvola R., Bruggeman C., Häyry P., Koskinen P. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation. 1997 Jun 17;95(12):2614–2616. doi: 10.1161/01.cir.95.12.2614. [DOI] [PubMed] [Google Scholar]
  37. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997 Dec 2;96(11):4095–4103. doi: 10.1161/01.cir.96.11.4095. [DOI] [PubMed] [Google Scholar]
  38. Maass M., Bartels C., Krüger S., Krause E., Engel P. M., Dalhoff K. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis. 1998 Oct;140 (Suppl 1):S25–S30. doi: 10.1016/s0021-9150(98)00117-8. [DOI] [PubMed] [Google Scholar]
  39. Mattila K. J., Valtonen V. V., Nieminen M. S., Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis. 1998 Mar;26(3):719–734. doi: 10.1086/514570. [DOI] [PubMed] [Google Scholar]
  40. Meydani M., Lipman R. D., Han S. N., Wu D., Beharka A., Martin K. R., Bronson R., Cao G., Smith D., Meydani S. N. The effect of long-term dietary supplementation with antioxidants. Ann N Y Acad Sci. 1998 Nov 20;854:352–360. doi: 10.1111/j.1749-6632.1998.tb09915.x. [DOI] [PubMed] [Google Scholar]
  41. Moazed T. C., Campbell L. A., Rosenfeld M. E., Grayston J. T., Kuo C. C. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis. 1999 Jul;180(1):238–241. doi: 10.1086/314855. [DOI] [PubMed] [Google Scholar]
  42. Molestina R. E., Miller R. D., Ramirez J. A., Summersgill J. T. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun. 1999 Mar;67(3):1323–1330. doi: 10.1128/iai.67.3.1323-1330.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Muhlestein J. B., Anderson J. L., Carlquist J. F., Salunkhe K., Horne B. D., Pearson R. R., Bunch T. J., Allen A., Trehan S., Nielson C. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation. 2000 Oct 10;102(15):1755–1760. doi: 10.1161/01.cir.102.15.1755. [DOI] [PubMed] [Google Scholar]
  44. Muhlestein J. B., Anderson J. L., Hammond E. H., Zhao L., Trehan S., Schwobe E. P., Carlquist J. F. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998 Feb 24;97(7):633–636. doi: 10.1161/01.cir.97.7.633. [DOI] [PubMed] [Google Scholar]
  45. Muhlestein J. B. Chronic infection and coronary artery disease. Med Clin North Am. 2000 Jan;84(1):123–148. doi: 10.1016/s0025-7125(05)70210-8. [DOI] [PubMed] [Google Scholar]
  46. Nicholson A. C., Hajjar D. P. Herpesvirus in atherosclerosis and thrombosis: etiologic agents or ubiquitous bystanders? Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):339–348. doi: 10.1161/01.atv.18.3.339. [DOI] [PubMed] [Google Scholar]
  47. Nieto F. J., Folsom A. R., Sorlie P. D., Grayston J. T., Wang S. P., Chambless L. E. Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999 Jul 15;150(2):149–156. doi: 10.1093/oxfordjournals.aje.a009974. [DOI] [PubMed] [Google Scholar]
  48. Nieto F. J. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol. 1998 Nov 15;148(10):937–948. doi: 10.1093/oxfordjournals.aje.a009570. [DOI] [PubMed] [Google Scholar]
  49. Nieto F. J. Viruses and atherosclerosis: a critical review of the epidemiologic evidence. Am Heart J. 1999 Nov;138(5 Pt 2):S453–S460. doi: 10.1016/s0002-8703(99)70274-7. [DOI] [PubMed] [Google Scholar]
  50. O'Neill C., Murray L. J., Ong G. M., O'Reilly D. P., Evans A. E., Bamford K. B. Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country. Epidemiol Infect. 1999 Feb;122(1):111–116. doi: 10.1017/s0950268898001757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Persoons M. C., Daemen M. J., van Kleef E. M., Grauls G. E., Wijers E., Bruggeman C. A. Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc Res. 1997 Nov;36(2):282–288. doi: 10.1016/s0008-6363(97)00189-2. [DOI] [PubMed] [Google Scholar]
  52. Reddy K. S., Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998 Feb 17;97(6):596–601. doi: 10.1161/01.cir.97.6.596. [DOI] [PubMed] [Google Scholar]
  53. Ridker P. M., Hennekens C. H., Buring J. E., Kundsin R., Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med. 1999 Oct 19;131(8):573–577. doi: 10.7326/0003-4819-131-8-199910190-00004. [DOI] [PubMed] [Google Scholar]
  54. Ridker P. M., Hennekens C. H., Stampfer M. J., Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998 Dec 22;98(25):2796–2799. doi: 10.1161/01.cir.98.25.2796. [DOI] [PubMed] [Google Scholar]
  55. Ridker P. M., Kundsin R. B., Stampfer M. J., Poulin S., Hennekens C. H. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999 Mar 9;99(9):1161–1164. doi: 10.1161/01.cir.99.9.1161. [DOI] [PubMed] [Google Scholar]
  56. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999 Jan 14;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  57. Seppälä H., Klaukka T., Vuopio-Varkila J., Muotiala A., Helenius H., Lager K., Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997 Aug 14;337(7):441–446. doi: 10.1056/NEJM199708143370701. [DOI] [PubMed] [Google Scholar]
  58. Siscovick D. S., Schwartz S. M., Corey L., Grayston J. T., Ashley R., Wang S. P., Psaty B. M., Tracy R. P., Kuller L. H., Kronmal R. A. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation. 2000 Nov 7;102(19):2335–2340. doi: 10.1161/01.cir.102.19.2335. [DOI] [PubMed] [Google Scholar]
  59. Smith K., Parsonnet J. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1997 Feb 20;336(8):587–588. doi: 10.1056/NEJM199702203360816. [DOI] [PubMed] [Google Scholar]
  60. Sorlie P. D., Nieto F. J., Adam E., Folsom A. R., Shahar E., Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med. 2000 Jul 10;160(13):2027–2032. doi: 10.1001/archinte.160.13.2027. [DOI] [PubMed] [Google Scholar]
  61. Speir E., Modali R., Huang E. S., Leon M. B., Shawl F., Finkel T., Epstein S. E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994 Jul 15;265(5170):391–394. doi: 10.1126/science.8023160. [DOI] [PubMed] [Google Scholar]
  62. Streblow D. N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayashi E., Ruchti F., Mattison K., Altschuler Y., Nelson J. A. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 1999 Nov 24;99(5):511–520. doi: 10.1016/s0092-8674(00)81539-1. [DOI] [PubMed] [Google Scholar]
  63. Strong J. P., Malcom G. T., McMahan C. A., Tracy R. E., Newman W. P., 3rd, Herderick E. E., Cornhill J. F. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999 Feb 24;281(8):727–735. doi: 10.1001/jama.281.8.727. [DOI] [PubMed] [Google Scholar]
  64. Thomas M., Wong Y., Thomas D., Ajaz M., Tsang V., Gallagher P. J., Ward M. E. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation. 1999 Jun 1;99(21):2733–2736. doi: 10.1161/01.cir.99.21.2733. [DOI] [PubMed] [Google Scholar]
  65. Wanishsawad C., Zhou Y. F., Epstein S. E. Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis. J Infect Dis. 2000 Feb;181(2):787–790. doi: 10.1086/315235. [DOI] [PubMed] [Google Scholar]
  66. Weis M., von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation. 1997 Sep 16;96(6):2069–2077. doi: 10.1161/01.cir.96.6.2069. [DOI] [PubMed] [Google Scholar]
  67. West R. Commentary: adjustment for potential confounders may have been taken too far. BMJ. 2000 Jul 22;321(7255):213–213. [PubMed] [Google Scholar]
  68. Whincup P., Danesh J., Walker M., Lennon L., Thomson A., Appleby P., Hawkey C., Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation. 2000 Apr 11;101(14):1647–1652. doi: 10.1161/01.cir.101.14.1647. [DOI] [PubMed] [Google Scholar]
  69. Williams K. J., Rodrigueza W. V. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 1998 Oct;9(5):511–513. doi: 10.1097/00041433-199810000-00018. [DOI] [PubMed] [Google Scholar]
  70. Wong Y. K., Dawkins K. D., Ward M. E. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol. 1999 Nov 1;34(5):1435–1439. doi: 10.1016/s0735-1097(99)00391-5. [DOI] [PubMed] [Google Scholar]
  71. Wu T. C., Hruban R. H., Ambinder R. F., Pizzorno M., Cameron D. E., Baumgartner W. A., Reitz B. A., Hayward G. S., Hutchins G. M. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol. 1992 Mar;140(3):739–747. [PMC free article] [PubMed] [Google Scholar]
  72. Zhou Y. F., Leon M. B., Waclawiw M. A., Popma J. J., Yu Z. X., Finkel T., Epstein S. E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996 Aug 29;335(9):624–630. doi: 10.1056/NEJM199608293350903. [DOI] [PubMed] [Google Scholar]
  73. Zhou Y. F., Shou M., Guetta E., Guzman R., Unger E. F., Yu Z. X., Zhang J., Finkel T., Epstein S. E. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999 Oct 5;100(14):1569–1575. doi: 10.1161/01.cir.100.14.1569. [DOI] [PubMed] [Google Scholar]
  74. Zhu J., Nieto F. J., Horne B. D., Anderson J. L., Muhlestein J. B., Epstein S. E. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001 Jan 2;103(1):45–51. doi: 10.1161/01.cir.103.1.45. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES